Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Schrodinger Inc (SDGR)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 3
  • 1 comments

Schrödinger, Inc. - Schrödinger Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

Avalo Therapeutics Inc. (AVTX)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 3
  • 1 comments

Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Market reaction Comment Full text

Vir Biotechnology (VIR)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 3
  • 1 comments

Vir Biotechnology - Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference

Market reaction Comment Full text

Spero Therapeutics Inc (SPRO)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 5
  • 1 comments

Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026

Market reaction Comment Full text

OUSTER, INC. (OUST)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 5
  • 1 comments

Ouster Announces Results for First Quarter 2026

Market reaction Comment Full text

NUVATION BIO INC. (NUVB)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 5
  • 1 comments

Nuvation Bio to Participate in Upcoming Investor Conferences

Market reaction Comment Full text

COUPANG, INC. (CPNG)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 4
  • 1 comments

Coupang Announces Results for First Quarter 2026

Market reaction Comment Full text

HINGE HEALTH, INC. (HNGE)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 8
  • 1 comments

Hinge Health reports record first quarter 2026 financial results

Market reaction Comment Full text

BLUELINX HOLDINGS INC. (BXC)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 3
  • 1 comments

BlueLinx Announces First Quarter 2026 Results

Market reaction Comment Full text

WOLFSPEED, INC. (WOLF)

  • Business News
  • May 05, 2026, 20:05 UTC
  • 3
  • 1 comments

Wolfspeed Reports Financial Results for the Third Quarter of Fiscal 2026

Market reaction Comment Full text
  • Previous
  • 441
  • 442
  • 443
  • 444
  • 445
  • Next

Search

News categories

  • Technical Exchange News(12425)
  • Event(6229)
  • SEC News(277261)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(159874)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin